Whalen Wealth Management Inc. Makes New $571,000 Investment in Merit Medical Systems, Inc. $MMSI

Whalen Wealth Management Inc. purchased a new position in shares of Merit Medical Systems, Inc. (NASDAQ:MMSI) in the second quarter, HoldingsChannel reports. The institutional investor purchased 8,238 shares of the medical instruments supplier’s stock, valued at approximately $571,000.

Several other hedge funds and other institutional investors have also modified their holdings of MMSI. Algert Global LLC grew its stake in shares of Merit Medical Systems by 119.7% in the second quarter. Algert Global LLC now owns 42,710 shares of the medical instruments supplier’s stock worth $2,962,000 after acquiring an additional 23,270 shares during the last quarter. Ranger Investment Management L.P. bought a new stake in Merit Medical Systems in the 2nd quarter valued at $9,045,000. Connor Clark & Lunn Investment Management Ltd. bought a new stake in Merit Medical Systems in the 2nd quarter valued at $12,923,000. Globeflex Capital L P acquired a new stake in Merit Medical Systems in the 2nd quarter worth $87,000. Finally, Elevation Point Wealth Partners LLC bought a new position in shares of Merit Medical Systems during the 2nd quarter worth about $376,000. Institutional investors and hedge funds own 99.66% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research analysts have recently commented on the stock. Bank of America upped their price objective on shares of Merit Medical Systems from $92.00 to $97.00 and gave the company a “neutral” rating in a research report on Thursday, August 13th. JPMorgan Chase & Co. boosted their price target on Merit Medical Systems from $77.00 to $95.00 and gave the company an “overweight” rating in a research note on Friday, July 31st. Wells Fargo & Company upped their price target on Merit Medical Systems from $74.00 to $83.00 and gave the company an “equal weight” rating in a report on Friday, July 31st. Barrington Research set a $114.00 price objective on Merit Medical Systems in a research report on Friday, July 31st. Finally, Robert W. Baird set a $98.00 price objective on Merit Medical Systems in a report on Friday, July 31st. Eight analysts have rated the stock with a Buy rating and four have issued a Hold rating to the stock. According to data from MarketBeat, Merit Medical Systems currently has a consensus rating of “Moderate Buy” and an average target price of $100.00.

Merit Medical Systems Trading Down 0.6%

Shares of MMSI opened at $90.28 on Tuesday. The company has a current ratio of 4.20, a quick ratio of 2.79 and a debt-to-equity ratio of 0.44. The stock has a market cap of $5.39 billion, a PE ratio of 37.31, a PEG ratio of 2.28 and a beta of 0.48. Merit Medical Systems, Inc. has a 1 year low of $59.74 and a 1 year high of $94.75. The stock has a 50 day simple moving average of $77.88 and a 200-day simple moving average of $72.58.

Merit Medical Systems (NASDAQ:MMSI) last announced its quarterly earnings results on Thursday, July 30th. The medical instruments supplier reported $1.19 EPS for the quarter, beating the consensus estimate of $0.96 by $0.23. Merit Medical Systems had a return on equity of 13.75% and a net margin of 9.22%.The business had revenue of $418.84 million for the quarter, compared to analyst estimates of $405.25 million. During the same quarter in the previous year, the firm earned $1.01 EPS. Merit Medical Systems’s quarterly revenue was up 9.5% on a year-over-year basis. Merit Medical Systems has set its FY 2026 guidance at 4.250-4.350 EPS. On average, sell-side analysts predict that Merit Medical Systems, Inc. will post 3.81 EPS for the current fiscal year.

About Merit Medical Systems

Merit Medical Systems, Inc is a global manufacturer and marketer of a broad range of medical devices used in diagnostic and interventional procedures. The company’s product portfolio encompasses vascular access, drainage, embolotherapy, and interventional oncology devices, as well as radiofrequency ablation systems and hemostasis solutions. These products serve physicians and hospitals in critical care settings and support minimally invasive treatment options across multiple specialties, including cardiology, radiology, oncology, neurology and endoscopy.

Founded in 1987 by Fred Lampropoulos, Merit Medical Systems has grown through both organic development and targeted acquisitions to expand its technology offerings and geographic reach.